Results 231 to 240 of about 143,709 (342)

Anti-CD20 antibody treatment in refractory Class IV lupus nephritis [PDF]

, 2006
Robert Carroll, Fiona G. Brown, Peter G. Kerr   +2 more
openalex   +1 more source

Neoadjuvant Therapy‐Induced Remodeling in Pancreatic Ductal Adenocarcinoma: Multimodal Spatial Analysis and Prognosis

Cancer Science, EarlyView.
Using integrated spatial pathomics and transcriptomics, we show that neoadjuvant therapy (NAT) in pancreatic ductal adenocarcinoma (PDAC) induces substantial tumor microenvironment remodeling that is not captured by tumor regression grading (TRG) alone.
Xiaofei Zhang, Ruoxin Lan, Danting Li, Yongjun Liu, Sonu Kalyan, Momin Iqbal, Nancy Liu, Jerry Zhang, Iman Hanna, Mala Gupta, Chaohui L. Zhao, Weiguo Liu, Jonathan Melamed, Michael Shusterman, Jessica Widmer, John Allendorf, Yao‐Zhong Liu   +16 more
wiley   +1 more source

Clonal IgG lambda plasmacytoma with Mott cell differentiation causing marked pleural effusion in a dog. [PDF]

J Vet Diagn Invest
Swenson CL, Nunnelley J.
europepmc   +1 more source

Bone marrow remission of hairy cell leukaemia induced by rituximab (anti‐cd20 monoclonal antibody) in a patient refractory to cladribine [PDF]

, 2000
Mark A. Hoffman, Lewis Auerbach
openalex   +1 more source

Cancer‐Specific Antihuman Podoplanin Antibody chLpMab‐2f Exerts Antitumor Effects Against Pleural Mesothelioma

Cancer Science, EarlyView.
Cancer‐specific antihuman podoplanin antibody chLpMab‐2f exerted antibody‐dependent cellular cytotoxicity and complement‐dependent cytotoxicity against pleural mesothelioma (PM) cell lines. Additionally, chLpMab‐2f inhibited tumor progression in mice with subcutaneously and intrathoracically transplanted human PM cells.
Aito Yoshida, Shinji Abe, Toshihiro Izumi, Satoshi Itakura, Keichiro Yamada, Takuya Wada, Takaaki Yamamoto, Chiemi Sato, Atsushi Mitsuhashi, Hirokazu Ogino, Seidai Sato, Tsutomu Shinohara, Masaki Hanibuchi, Mika K. Kaneko, Yukinari Kato, Yasuhiko Nishioka   +15 more
wiley   +1 more source

Prognostic value of tumor-infiltrating lymphocytes, tumor associated neutrophils and metabolic checkpoint molecules on survival of patients with metastatic pancreatic ductal adenocarcinoma. [PDF]

Surg Pract Sci
Zhang T, Miksch RC, Aghamaliyev U, Weniger M, Günther M, Ormanns S, Parsa F, D'Haese JG, Bazhin AV, Ilmer M, Renz BW, Werner J.   +11 more
europepmc   +1 more source

Diffuse large B‐cell lymphoma on the back of a patient with AIDS: Successful treatment by the CD20 monoclonal antibody rituximab [PDF]

, 2005
Constanze Voigtländer, Thomas Harrer, Lothar Schneider, Hendrik Schulze‐Koops, Gerald Niedobitek, Matthias Lüftl   +5 more
openalex   +1 more source

Immune‐related toxicity profile after haematopoietic stem cell transplantation in patients with B‐ALL given combination immunotherapy with rituximab, inotuzumab and blinatumomab

British Journal of Haematology, EarlyView.
Olayinka Okeleji, David McCall, Branko Cuglievan, Amber Gibson, Demetrios Petropoulos, Priti Tewari, Jeremy Connors, Irtiza N. Sheikh   +7 more
wiley   +1 more source

Ethical and Regulatory Considerations in the Clinical Translation of Pluripotent Stem Cell‐Derived NK Cell Therapies

Cell Proliferation, EarlyView.
Advancements in the generation of human pluripotent stem cell‐derived natural killer (PSC‐NK) cells have attracted considerable attention within the biomedical research community, offering a promising off‐the‐shelf technique for universal immune therapy.
Qianwen Chen, Jianwei Lv, Xinwei Xie, Hanlin Zhu, Zhenyu Xiao, Yaojin Peng   +5 more
wiley   +1 more source

Successful Therapy with Obinutuzumab in a Toddler with Primary Multidrug-Resistant Nephrotic Syndrome. [PDF]

J Clin Med
Drozynska-Duklas M, Zagozdzon I, Chudzik I, Balasz-Chmielewska I, Kranz A, Zurowska A.   +5 more
europepmc   +1 more source